Ad hoc-Mitteilungen

Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million

| Aufrufe: 195

Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million

The Extraordinary General Meeting of Acarix AB ("Acarix" or the "Company") resolved on 23 November 2021 to carry out a new share issue with preferential rights for the Company's existing shareholders at a subscription price of SEK 0.75, which may provide the Company with approximately SEK 79.3 million before deduction of cost related to the rights issue (the "Rights Issue"). The board of directors of Acarix has in connection with the Rights Issue, and prior to the subscription period which commence 1 December 2021, prepared a prospectus which today has been approved by the Swedish Financial Supervisory Authority (the "SFSA"). The Rights Issue is fully guaranteed.

Publication of the prospectus

For complete information about the Rights Issue, please refer to the prospectus that has been prepared by the Company and that today has been approved by the SFSA. The prospectus is available on the Company's website (www.acarix.com) and on Redeye AB's ("Redeye") website (www.redeye.se) and will also in a couple of days be available on the SFSA's website (https://fi.se/sv/vara-register/prospektregistret/). The prospectus has only been prepared in Swedish.

The prospectus is prepared as an EU-Growth prospectus in accordance with article 15 in the Regulation (EU) 2017/1129 (the "Prospectus Regulation"). The prospectus has been approved by the SFSA, which is the Swedish competent authority in accordance with the Prospectus Regulation, in accordance with article 20 in the Prospectus Regulation. The SFSA only approves the prospectus as meeting the standards of completeness, comprehensibility and consistency imposed by the Prospectus Regulation. The approval should not be considered as an endorsement of Acarix or as an endorsement of the quality of the shares that are the subject of the prospectus and does not indicate that the SFSA guarantees that the facts in the prospectus are correct or complete. Investors should make their own assessment as to the suitability of investing in the Rights Issue.

  • 1 - 15 December 2021 - Subscription period
  • 1 - 10 December 2021 - Trading in subscription rights
  • 1 December 2021 - Trading in BTA until the Rights Issue has been registered with the Swedish Companies Registration Office
  • 20 December 2021 - Announcement of the outcome of the Rights Issue
Investment meetings

Attachment

""
""

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.